3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Ulcer
1
Tomaculous neuropathy
1
Thrombocythemia, Essential
1
Stomatitis
1
Stomach Neoplasms
1
Radiation Pneumonitis
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Polycystic Ovary Syndrome
1
Neuroma
1
Myeloproliferative Disorders
1
Median Neuropathy
1
Lung Neoplasms
1
Lung Diseases, Interstitial
1
Hand Injuries
1
Disease
1
Carpal Tunnel Syndrome
1
Breast Neoplasms
1
Interventions
Blood Specimen Collection
3
Observation
2
Magnetic Resonance Imaging
2
Biopsy
2
tislelizumab
1
pembrolizumab
1
fluorocholine
1
atezolizumab
1
abiraterone
1
Videotape Recording
1
TIC10 compound
1
Surveys and Questionnaires
1
Specimen Handling
1
Referral and Consultation
1
Prostatectomy
1
Preoperative Exercise
1
Prednisone
1
Positron Emission Tomography Computed Tomography
1
Pluvicto
1
Nephroureterectomy
1
Mass Screening
1
Mammography
1
Interleukin-15
1
High-Intensity Interval Training
1
Hematologic Tests
1
Food
1
Endosonography
1
Educational Status
1
Diagnostic Techniques and Procedures
1
Diagnostic Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Disease
×
Acetylcysteine
×
Clear all
NCT04460521
2024-08-23
ACTS
Nova Scotia Health Authority
Phase 4
Recruiting
240 enrolled